Literature DB >> 18043429

Assessment of changes in cochlear function with pneumolabyrinth after middle ear trauma.

William W Lao1, John K Niparko.   

Abstract

OBJECTIVE: To describe a case of pneumolabyrinth secondary to tympanic membrane/ossicular trauma and the subsequent recovery of sensorineural hearing loss managed with conservative measures. PATIENTS: A 15-year-old boy presented to an outside hospital with signs and symptoms of acute hearing loss, vertigo, and tinnitus after penetrating injury to his right tympanic membrane. In addition, computed tomography demonstrated air density within the vestibule.
INTERVENTIONS: The patient was managed conservatively with bed rest, avoidance of straining, corticosteroids, and antibiotics. MAIN OUTCOME MEASURES: Computed tomography, audiologic testing.
RESULTS: Patient recovered near-normal hearing subjectively. There was closure of the air-bone gap (<or=20 dB) along with resolution of air within vestibule.
CONCLUSION: We presented a case of a patient with pneumolabyrinth secondary to penetrating trauma to his tympanic membrane. With supportive treatment, air within the labyrinth resorbed, and the patient recovered sensorineural function. Comparing with the mixed successes of surgical repairs, we propose that initial management for traumatic pneumolabyrinth should be first treated conservatively in the absence of worsening symptoms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18043429     DOI: 10.1097/MAO.0b013e31815a9f2b

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  2 in total

Review 1.  Pneumolabyrinth: a systematic review.

Authors:  Cecilia Botti; Andrea Castellucci; Francesco Maria Crocetta; Martina Fornaciari; Davide Giordano; Chiara Bassi; Angelo Ghidini
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-21       Impact factor: 2.503

2.  Perilymphatic fistula and pneumolabyrinth without temporal bone fracture: a rare entity.

Authors:  Ana Sousa Menezes; Daniela Ribeiro; Daniel Alves Miranda; Sara Martins Pereira
Journal:  BMJ Case Rep       Date:  2019-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.